Prosecution Insights
Last updated: October 27, 2026

Moussa Maher Haddad, USPTO Patent Examiner

Listed by the USPTO as HADDAD, MOUSSA MAHER

Tech Center 3700 • Art Units: 3792 3796

This examiner grants 27% of resolved cases

Analysis

Moussa Maher Haddad has handled 90 resolved cases in Tech Center 3700. His allowance rate is 26.7%, and the median days to allowance is 1350. In Art Unit 3792, he offers a 33.0% interview lift, which significantly improves the chances of overcoming the low 26.7% baseline allowance rate.

Top companies in his docket include Northwestern University, West Affum Holdings Dac, and Covidien L.P. The firms Knobbe, Martens, Olson & Bear, LLP, Nolte Lackenbach Siegel, and QUARLES & BRADY LLP frequently represent applicants here. These parties face a challenging 26.7% allowance rate and a long 1350-day median pendency.

The 33.0% interview lift is a critical data point for practitioners, as it suggests that direct communication is a primary driver for successful outcomes. Given the 1350-day median wait, an early interview might be a strategic necessity to navigate the 26.7% allowance environment in Tech Center 3700. The 90 resolved cases provide the basis for these figures.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

26.7%
Allow Rate
-43.3% vs TC avg
156
Total Applications
+33.0%
Interview Lift
1350
Avg Prosecution Days
Based on 90 resolved cases, 2023–2026

Rejection Statute Breakdown

20.0%
§101 Eligibility
12.8%
§102 Novelty
36.4%
§103 Obviousness
26.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17872970 SYSTEM AND METHOD FOR CAPTURING CARDIOPULMONARY SIGNALS Final Rejection Apple Inc.
18913051 AUTOREGULATION MONITORING USING DEEP LEARNING Non-Final OA COVIDIEN LP
18295717 NON-CONTACT MONITORING FOR NIGHT TREMORS OR OTHER MEDICAL CONDITIONS Final Rejection Covidien LP
17644129 DETECTION AND/OR PREDICTION OF STROKE USING IMPEDANCE MEASUREMENTS Non-Final OA Covidien LP
17070968 EXAMINATION APPARATUS FOR MEDICAL EXAMINATION OF AN ANIMAL Final Rejection Boehringer Ingelheim Vetmedica GmbH
18033659 FATIGUE LEVEL ESTIMATION APPARATUS, FATIGUE LEVEL ESTIMATION METHOD, AND COMPUTER-READABLE RECORDING MEDIUM Final Rejection NEC Corporation
17913648 CARDIAC RHYTHM MANAGEMENT SYSTEM AND METHOD Non-Final OA BIOTRONIK SE & Co. KG
18073067 SMART MACHINES AND MACHINE LEARNING FOR HEMODYNAMIC SUPPORT DEVICES Non-Final OA ABIOMED, Inc.
18847404 IMPLANTABLE STIMULATING ASSEMBLY WITH MUSCLE Non-Final OA COCHLEAR LIMITED
17918827 COMPENSATION OF BALANCE DYSFUNCTION Final Rejection Cochlear Limited
17676396 Therapy Electrode Mesh Interface for Wearable Cardiac Therapeutic Devices Final Rejection ZOLL Medical Corporation
18648764 ELECTRICAL MODULATION FOR THE TREATMENT OF BRAIN TUMORS Non-Final OA Northwestern University
17287668 APPARATUS AND METHOD FOR MEASURING PHYSIOLOGICAL PARAMETERS OF MAMMAL SUBJECT AND APPLICATIONS OF SAME Final Rejection NORTHWESTERN UNIVERSITY
17287168 SENSOR NETWORK FOR MEASURING PHYSIOLOGICAL PARAMETERS OF MAMMAL SUBJECT AND APPLICATIONS OF SAME Final Rejection NORTHWESTERN UNIVERSITY
17807192 LATENCY COMPENSATION FOR DETECTION OF ECAPS Non-Final OA Medtronic, Inc.
18448834 WEARABLE PHYSIOLOGICAL MONITORING DEVICE Non-Final OA Masimo Corporation
17987255 SYSTEM AND METHOD FOR DISEASE RISK ASSESSMENT AND TREATMENT Final Rejection PercuSense, Inc.
18678782 VALVE BYPASS TOOL FOR AN IMPLANTABLE MEDICAL DEVICE DELIVERY SYSTEM AND METHOD OF IMPLANTING A MEDICAL DEVICE Final Rejection Pacesetter, Inc.
19031937 WEARABLE MEDICAL DEVICE IMPLEMENTING LOW POWER COMMUNICATION Non-Final OA West Affum Holdings DAC
18914710 WCD WITH PACING ANALGESIA Non-Final OA West Affum Holdings DAC
17514311 INTEGRATIVE WEARABLE HEALTH MONITORING Non-Final OA West Affum Holdings DAC
17782559 Pudendal Nerve Burst Stimulation for Bladder Control Non-Final OA Duke University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Moussa Maher Haddad's allowance rate?

26.7% of resolved applications examined by Moussa Maher Haddad were allowed (90 resolved cases), compared with 66.7% across Art Unit 3792 over the last five years.

Does an interview help with examiner Moussa Maher Haddad?

This examiner's interview lift is +33.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Moussa Maher Haddad take to allow a patent?

Applications allowed by Moussa Maher Haddad took 1,350 days on average from filing to allowance.

Which art unit does examiner Moussa Maher Haddad work in?

Moussa Maher Haddad examines applications in Art Unit 3792 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month